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Abstract
Background Vitreoretinal surgeons have been slow to adopt
the use of spectral filters for endoillumination to reduce
retinal light toxicity. This study shows that spectral filters
can be used without a loss in color contrast during brilliant
blue G chromovitrectomy.
Methods To evaluate the influence of intra operative spectral
light filters on perceivable contrast during Brilliant Blue G
chromovitrectomy, a prospective, observational clinical study
was carried out on 59 consecutive Brilliant Blue G chromo-
vitrectomy interventions in 59 patients admitted for macular
holes, macular pucker or vitreomacular traction syndromes.
Subsequent to peeling of the internal limiting membrane, six
different illumination modes were enabled consecutively: mer-
cury vapor, mercury vapor/xenon, and xenon followed by
xenon combined with an amber, green or yellow spectral filter.
Main outcome measure was the chromaticity spread between
stained internal limiting membrane and unstained retina as a
measure for the color contrast perceived by the human eye.
Results Mean chromaticity scores were similar for all light
sources: mercury vapor 7.97, mercury vapor/xenon 7.96
(p =0.96), and xenon 7.41 (p =0.55). Compared to xenon,
the additional use of endoillumination spectral filters did not
change contrast recognizability: Chromaticity scores were
9.38 for the amber filter (p =0.13), 6.63 for the green and
7.02 for the yellow filter (p =0.37 and 0.64, respectively).
When comparing the different filters head-to-head, the amber
filter was superior to the green filter (p =0.03), while the
yellow was intermediate and not significantly different from
either the amber (p =0.08) or the green filter (p =0.51).
Conclusions Color contrast perceptibility during Brilliant
Blue G assisted chromovitrectomy is similar with mercury
vapor, mercury vapor/xenon or xenon light sources. Spectral
filters do not decrease color contrast recognizability. Head-to-
head comparison shows a significant advantage for the amber
over the green filter with respect to contrast generation, the
yellow filter is intermediate. As spectral filters are known to
greatly reduce retinal light toxicity, we suggest donor eye
studies to validate whether the amber filter should be generally
recommended for Brilliant Blue G chromovitrectomy.
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Introduction
Light-induced toxicity to the retina and the retinal pigment
epithelium (RPE) from fiberoptic endoillumination during vit-
rectomy has been well established [1–3]. This phenomenon is of
particular clinical relevance in macular surgery [4]. One of the
most frequent interventions in macular surgery is the removal of
the internal limiting membrane (ILM). The use of vital dyes in
order to stain the ILM and improve its visibility is frequently
referred to as chromovitrectomy [5] or chromodissection[6] and
is now accepted as a standard treatment for diseases related to
vitreomacular traction [7]. An additional increase in cellular
susceptibility to light toxicity may develop through the use of
several vital dyes [8, 9], including Brilliant Blue G (BBG),
although clinical significance has only been demonstrated for
indocyanine G (ICG) [8]. Brilliant Blue G is currently the only
ILM-specific vital dye which is approved for intravitreal use in
the European Union. Spectral filters have been proposed for
several decades to significantly reduce retinal and retinal pig-
ment epithelium light toxicity through the reduction of the
endoillumination short-wavelength spectrum [4, 10]. Spectral
filters, also referred to as pass filters, are featured in many
commercially available endoilluminator devices but only few
surgeons rely on their use despite a growing body of evidence
for their protective effect [3, 4, 11–13]. The influence of pass
filters on the surgeon’s intraoperative visual discrimination has
been a matter of speculation for many years [4]. Objective
clinical analyses are not available to our knowledge. We suspect
that surgeons are concerned that the use of spectral filters might
reduce visual control during chromovitrectomy. On the other
hand, a preclinical examination recently suggested that spectral
filters as well as polarizing filters may in fact improve
intraoperative color contrast [14]. The present clinical study
intends to objectify the influence of spectral light filters on
intraoperative recognizability of the contrast between the stained
ILM and unstained retina in BBG chromovitrectomy.
Methods
In a prospective, observational clinical study, we analyzed 59
consecutive chromovitrectomy interventions in 59 patients
from one study center. Patients had been admitted for macular
holes, macular pucker or vitreomacular traction syndromes.
Exclusion criteria included patient age under 18 years, previ-
ous chromovitrectomies within the preceding 6 months and
the use of additional vital dyes during the same intervention,
including the application of trypan blue in order to visualize
epiretinal material. Subjects were also excluded if videos did
not permit the identification of posterior pole anatomic land-
marks, including the optic disc, vascular arcades and the
macula due to poor video quality or artifacts.
All patients underwent routine 23-gauge vitrectomy,
performed by two surgeons (CV, CL) using the Stellaris PC
surgical platform (Bausch & Lomb™ Surgical, Aliso Viejo,
CA/USA). This device is commercially equipped with two
different integrated light sources for endoillumination: one
xenon light source and one combined mercury and xenon light
source. It also disposes of green, yellow and amber spectral
filters which, if activated with a switch, filter the emission
spectrum generated by the xenon light source before the light
is conveyed to the endoillumination hand piece. The operating
theater setup was also fitted with an additional external mercury
vapor light source (Photon II™, Synergetics™, Inc. O’Fallon,
MO/USA). The relative spectral output for the examined light
sources and filters are depicted in Fig. 1 (mercury vapor and
xenon light) and in Fig. 2 (green, yellow and amber filter),
respectively. Following complete posterior vitreous detach-
ment, 0.5 ml of a heavier than water BBG solution from
ready-to-use vials (Brilliant Peel®, Geuder AG, Heidelberg,
Germany) were injected into the vitreous cavity at a concen-
tration of 0.25 mg/ml, with clearance occurring after 10 s. The
distance from the posterior retinal pole during injection was
approximately 3 mm. According to the manufacturer, this
0.25 g/l solution of heavier than water BBG has an absorption
maximum of 584.0 nm at a pH of 7.52 and an osmolarity of
306 mOsm/kg H2O. Its specific weight is 1.017–1.019 g/cm³.
BBG is approved for intravitreal use in the European Union but
not in the United States.
Mechanical removal of the ILM was performed under mer-
cury vapor endoillumination (Photon II™, Synergetics™, Inc.
O’Fallon, MO/USA) in combination with a widefield diffusion
light pipe (56.21.23P, Synergetics™, Inc. O’Fallon,MO/USA).
After completion of the peeling process, optimum lighting was
sought for digital video recordings of the posterior pole. The
same region was consecutively taped under 6 different illumi-
nation modes: Following mercury vapor illumination, both the
mercury vapor/xenon and the xenon light sources incorporated
in the surgical platform were enabled and recorded in combi-
nation with a wide field endoillumination cannula (BL5823
wide field illuminator, Bausch & Lomb™ surgical, Aliso
Viejo, CA/USA). Subsequently, the built-in amber, green and
yellow filters were swung in successively and recorded in
combination with xenon illumination.
For video recordings, a Panasonic LQ-MD800E digital re-
cording system (Panasonic Corporation, Osaka, Japan) with a
Leica 2 Type 10446585 video camera, attached to a LeicaM841
Ophthalmic Microscope (Leica Microsystems GmbH, Wetzlar,
Germany) was used. Routine exposure and calibration align-
ments of the recording system were performed at the beginning
of each intervention, adjusting thewhite balance of the recording
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system to a standardized balancing screen (XpoBalance®,
Lastolight Ltd., Coalville, Leics, United Kingdom).
Main outcome measure was the chromaticity spread be-
tween stained ILM and the unstained retina based on a method
we now refer to as chromaticity analysis. The methodology is
described in detail elsewhere [15]. Its objective is to quantify
the color contrast between the stained ILM and unstained
retina as it is perceived by the human eye. Briefly, individual
still images without imaging artifacts were selected from each
video. Two regions of interest (ROI) were marked in each of
the images near the posterior pole and within the temporal
vascular arcades by a vitreoretinal surgeon (PBH): One of the
ROIs was plotted in an area with maximally stained ILM. A
second ROI of similar extension was selected in an area where
the ILM had already been removed during the course of the
operation (Figs. 3 and 4). Based on the wavelengths captured
by the charge-coupled device (CCD) of the camera, a custom
made software tool programmed in MATLAB (Version
R2007b) calculated the average color of each of the two
ROIs. The averaged wavelengths were projected into the
CIELAB (CIE 1976 L*,a*,b*) color space, a vector space
diagram, in which all visible colors are plotted according to
their discriminability by the human eye. It is based on empir-
ical analyses of human visual sensitivities to color differences
from the 1940s [16]. The original diagram featured multiple
ellipsoid regions. Each ellipse contained a multitude of colors
indistinguishable from the color in the center of the ellipse for
the human eye. However, size and orientation of the regions
varied depending on the center color, which was felt to be
unpractical. An attempt to create a less distorted representation
lead to an arrangement where the ellipses were converted into
equidistant circles of colors indistinguishable from the color in
the center of each circle. Distances between individual colors
were now directly proportional to their discriminability by the
human visual system. Distances within the CIELAB space can
be regarded as a direct measure for the strength of perceivable
color contrast [17]. They can be expressed quantitatively as
chromaticity scores. Within the CIELAB color space, each
color is uniquely defined by the L*, a* and b* values. To
ensure invariance to different lighting, the lightness L* was
excluded from our calculations. Chromaticity scores are, thus,
given by the Euclidean distance of the two colors in the a*/b*-
plane and are in arbitrary units. Altogether, 324 chromaticity
measurements were performed.
Fig. 1 Blue line: Mercury vapor (a) and xenon (b) endoillumination relative spectral output. Pink line: Relative photopic eye response curve. Yellow
line: Relative aphakic hazard [3]. The ordinate displays a decimal division, the abscissa the wavelength in nanometers
Fig. 2 Blue line: xenon+green filter (a) xenon+yellow filter (b) and
xenon+amber filter (c) endoillumination relative spectral output. Pink
line: Relative photopic eye response curve. Yellow line: Relative aphakic
hazard [3]. The ordinate displays a decimal division, the abscissa the
wavelength in nanometers
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Statistically significant levels were calculated using the
software package R Version 2.12.1 [18]. Normality of the
distributions was tested with the Kolmogorof–Smirnov test
and all our measurements were normally distributed.
To compare subgroup mean values one way ANOVA’s
were performed. Results were presented as F-values of the
ANOVAs with corresponding p -values. In case of non-
significance, no further comparisons of subgroups were
needed. In case of significance, subsequent pairwise t -tests
would have been performed. To adjust p -values for multi-
ple comparison, the Holmes correction method would have
been applied. A p-value smaller than 0.05 was considered
statistically significant for all t -tests and ANOVAs in this
study.
Results
A total of 59 consecutive chromovitrectomy interventions in
59 patients from one study center were analyzed. Indications
for chromovitrectomy included macular holes (N=18), macular
pucker (N=38) or vitreomacular traction syndromes (N =3); 36
right eyes and 23 left eyes were included. Patient age
ranged from 45 to 82 years (median 72), and 27 patients
were female while 32 were male. All patients were
pseudophakic. Mean chromaticity scores were similar for
all light sources: Mercury vapor 7.97, mercury vapor/xenon
7.96 (p =0.96 compared to mercury vapor), and xenon 7.41
(p =0.55 compared to mercury vapor). Compared to xenon,
the additional use of endoillumination spectral filters did
not change contrast recognizability. Chromaticity scores
were 9.38 for the amber filter (p =0.13), 6.63 for the green
and 7.02 for the yellow filter (p =0.37 and 0.64, respective-
ly). When comparing color contrast recognizability with the
different filters head-to-head, the amber filter was superior
to the green filter (p =0.03). The yellow filter was interme-
diate compared to the amber (p =0.08) or the green filter
(p =0.51) (Fig. 5). Chromaticity data for all subgroups
revealed a Gaussian distribution. Comparison of disease
subgroup mean values revealed a p-value of 0.21.
Fig. 3 Screenshot displaying the
same region of the fundus with
plotted regions of interest (ROIs;
long arrow) under different
lighting: mercury-vapor (a),
mercury-vapor–xenon (b) and
xenon (c). The border between
the stained ILM and the unstained
underlying retina can be clearly
appreciated (short arrow)
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Discussion
Visual discrimination is essential for successful macular surgery.
Stronger fiberoptic light sources and vital dyes have increased
the ease, thoroughness, and safety of chromovitrectomy inter-
ventions [7]. Stronger light sources and the use of vital dyesmay
also increase cellular light toxicity, however, through increased
light exposure and phototoxicity [9]. Light toxicity may be
counteracted through the elimination of particularly hazardous
wavelengths from the emission spectrum before entering the eye
through the fiberoptic system. This approach involves the use of
spectral filters and has been established for many years [4].
Many modern endoillumination devices feature a variety of
built-in pass filters, yet vitreoretinal surgeons have been slow
to adopt their use. When considering the established protective
effects of spectral filters [3, 4, 11–13], a likely explanation for
the surgeons’ reservations lies in a concern over possible inter-
ference with intraoperative visual control. The relatively scarce
literature on the matter does not, however, endorse such reser-
vations; objective clinical analyses are not available, but
surgeons have reported, in fact, improved visual discrimination
with yellow filters [4, 19] and recently a preclinical study
confirmed that the contrast between the stained ILM and
unstained retina may be improved through the use of a pass
filter which eliminates all wavelengths shorter than 500 nm
during BBG chromovitrectomy on post-mortem porcine eyes
[14]. The favorable effect of tinted glasses on visual function has
been known since ancient times [20]. Yellow and amber filters
have been described to increase contrast perception by a reduc-
tion of ocular media light scatter and decreased chromatic
aberration [20]. Visual acuity studies have shown, that yellow
and amber tinted lenses may increase contrast sensitivity to
white on blue gratings 1.23 and 1.43-fold, respectively: blue
light is absorbed, reducing the luminance of the blue surface and
hence improving the apparent contrast of the lighter objects [21].
The capacity of the human visual system to recognize color
contrasts is not linear; some color contrasts can be differenti-
ated more easily than others. In order to allow our results to
meaningfully describe the surgeon’s capacity to perceive the
color contrast between the stained ILM and the unstained
Fig. 4 Screenshot displaying the
same region of the fundus with
plotted regions of interest (ROIs;
long arrow) under xenon lighting
combined with Amber (a), green
(b) and yellow spectral filters (c).
The border between the stained
ILM and the unstained underlying
retina can be clearly appreciated
(short arrow)
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retina, we chose the chromaticity analysis method [22]. This
method first calculates the average color contained in the two
ROIs selected in each image. The averaged wavelengths are
then projected into the CIELAB (CIE 1976 L*,a*,b*) color
space. Distances within the CIELAB space can be regarded as
a direct measure for the strength of perceivable color contrast
[17]. They can be expressed quantitatively as chromaticity
scores. The higher the chromaticity score the better the two
colors can be differentiated by the observer.
Light-induced retinal toxicity is determined by the emis-
sion spectrum, power, and duration of application of
endoillumination as well as by the distance between the light
pipe and the retina [2]. Short wavelength irradiation, such as
blue and ultraviolet rays, is particularly hazardous [3] as
wavelengths under 400 nm have been shown to compromise
photoreceptor function in addition to mediating the RPE dam-
age seen across the entire spectrum of visible light exposure
[2]. Overall phototoxic retinal exposure is 10 times higher at
435 nm compared to a 500 nm wavelength [23].
Different light sources feature distinct emission spectra
with diverging short wavelength spectral radiances.
Photosensitizing dyes additionally prompt photochemical
retinal damage by increasing levels of free radicals as an
overlap of the endoilluminator emission spectrum and the vital
dye absorbance spectrum provokes the absorbance of
endoillumination light by the dye-stained retina. This phe-
nomenon is particularly relevant in the case of ICG [8, 24].
For several other vital dyes, including BBG, a decrease in
cellular viability has been described in connection with the
presence of visible light, although a clinically measurable
effect has not been observed at conventional dosages [9].
Among the investigated endoillumination devices, xenon
illumination, due to its emission spectrum, presents a higher
phototoxicity hazard than mercury vapor light [3, 25] (Fig. 1).
Exposure times to reach a safety limit defined by ISO 15004–
2:2007 are 1.9 times shorter for xenon than for mercury vapor
light (Table 1). The protective effects of spectral filters can
also be expressed as an increment in exposure times necessary
to reach the predefined ISO 15004–2:2007 safety limit
(Table 1). Among the filters incorporated in the surgical
platform used for the present clinical study, the amber filter
allows the most resolute elimination of short wavelengths.
The resulting reduction in light toxicity allows exposure times
more than three times higher than white xenon light to reach
the exposure limit. The protective effects are less pronounced
for the yellow filter and even less so for the green filter.
Our results show that a diligent choice of the endo-
illumination light source and the activation of appropriate
additional spectral filters allow operating with significantly
reduced retinal and RPE light toxicity without compromising
in terms of color contrast performance: While no difference
with regards to contrast performance was observed in our
study, mercury vapor light sources have a more favorable light
toxicity profile than xenon light sources. None of the incor-
porated spectral filters significantly changed color contrast
discriminability compared to white xenon light. When com-
paring the different filters head-to-head, the amber filter was
significantly superior to the green filter. Contrast strength
registered with the use of the yellow filter was in between that
of both other filters, statistical significance was not reached.
Comparatively good contrast values for the amber filter are
in line with earlier observations that filters which reduce the
Fig. 5 Mercury vapor, xenon–
mercury and xenon light sources
produce comparable contrasts in
BBG chromovitrectomy. The use
of intraoperative light filters also
does not significantly alter BBG
performance with respect to
contrast formation. The ordinate
displays the CIELAB score. The
upper and lower margins of the
boxes in this standard box-and-
whisker diagram represent the
25th and the 75th, the central line
inside the box the 50th percentile
(median). The whiskers mark the
minimum and the maximum, with
some outliers plotted as small
circles
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short wavelength emission spectrum increase color contrast
sensitivity by reducing ocular media light scatter and chro-
matic aberration and with a preclinical analyses which show
that pass filters may allow excellent contrast performance
[14]. Blue light absorption leading to improved discriminabil-
ity of surrounding lighter structures may also play a role. The
favorable performance of the amber filter is also endorsed by
the finding that its spectrum coincides more than that of any
other tested filter or light source with the BBG absorption
spectrum. Complete overlap of the spectra would generate a
binary image where only unstained tissue would reflect the
amber light, thus, maximizing contrast, although at the ex-
pense of reduced luminance. Generally, the reduction in reti-
nal photo toxicity needs to be weighed against lower overall
levels of luminance and reduced color discriminability [11,
14, 21]. Luminance has been described to drop to 14-71 %
through the use of a pass filter with a cut-off at 500 nm in a
preclinical study, although illumination was still considered
sufficient for ILM removal [14]. Luminance was excluded in
the present study, as it is subject to interference from incon-
sistent angles of illumination and variable distance between
the illumination probe and the retinal surface. The cut-off of
the amber filter of roughly 550 nm is similar to the one used in
the preclinical study so that a similar reduction in luminance is
to be expected. We speculate that reduced luminance contrast,
apart from a subjective preference for white light may, in part,
explain the sluggish adoption of spectral endoillumination
light filters among vitreoretinal surgeons. Donor eye studies
are suggested to validate the feasibility of ILM removal under
amber filter endoillumination, before a general recommenda-
tion for its routine use can be made.
Spectral filter options are also included in a number of
other commercially available endoillumination light sources.
Similar effects on retinal light toxicity and color contrast can
be expected, although variations in the light spectrum suggest
that our results should not be directly extrapolated to other
devices. Presently, apart from the Stellaris PC surgical plat-
form (Bausch & Lomb™ surgical, Aliso Viejo, CA/USA) the
Brightstar Illumination System (D.O.R.C. Dutch Ophthalmic
Research Center International B.V. Zuidland, The Netherlands;
cut-offs at 435 nm, 475 nm, 515 nm), and the Synergetics
Photon 1 and 2 (Synergetics Inc., O’Fallon, Missouri, USA;
cut-offs at 485 nm) all offer filter options.
Limitations of the methodology include the fact that the
type of stained tissue, e.g. ILM vs. epiretinal material, was not
monitored histologically and that the extension of analyzed
retinal surface was not standardized per patient. ROIs were
chosen manually by a retinal surgeon in an area with maxi-
mum contrast in each image: The results reflect the color
contrast of areas with highest contrast according to the per-
ception of the interpreting retinal surgeon, not an average of
the posterior pole. We believe that the measurement of highest
contrast may be clinically more meaningful than the posterior
pole average; however, as the difficult elevation of the first
ILM flap is generally performed in an area with optimum
staining. Also, the comparison of areas with maximum con-
trasts minimizes bias by epiretinal material.
The patient population used in this study consists of a
group of three related diagnoses, whose configurations might
influence staining characteristics. However, ANOVA sub-
group variance analyses showed a p-value of 0.21, revealing
that staining was not affected by the underlying pathology.
Conclusions
Color contrasts between the ILM and the underlying retina
perceived by the human eye during BBG-assisted chromo-
vitrectomy are similar with the use of mercury vapor, mercury
vapor/xenon and xenon light sources. The use of spectral filters
Table 1 Time to exceed 10 J/cm2 weighted radiant exposure guideline, in minutes
Lamp: Mercury Xenon
Spectral filter: None Amber Green Yellow None Amber Green Yellow
Setting (%)
100 29 >120 33 44 16 >120 18 23
60 49 >120 56 73 26 >120 30 39
50 58 >120 67 87 32 >120 36 46
40 (=default) 73 >120 84 109 39 >120 45 58
30 97 >120 112 >120 53 >120 60 77
20 >120 >120 >120 >120 79 >120 89 116
10 >120 >120 >120 >120 >120 >120 >120 >120
Table [26]: Time to exceed the 10 J/cm2 ISO 15004–2:2007weighted radiant exposure limit in minutes with the two different light sources featured in the
Bausch& Lomb Stellaris PC surgical platform. The photo toxicity hazard is lower withmercury vapor thanwith xenon illumination and can be gradually
further reduced with the use of the green, yellow and amber spectral filter, respectively. Note: The exposure from all light sources is cumulative and
additive
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also does not significantly alter color contrast recognizability
compared towhite xenon light.When comparing different filters
head-to-head, the amber filter produces significantly better color
contrasts than the green filter, while yellow filter performance is
intermediate with no statistical significance. The amber filter
coincidentally offers higher protection from light toxicity than
the yellow or the green filter.
In the context of this prospective clinical analysis, it is
suggested that for the choice of the light source and spectral
filter in BBG-assisted chromovitrectomy, light toxicity should
be taken into account, favoring mercury vapor illumination
and the use of the amber filter. Donor eye studies are needed to
validate practicability, before a general recommendation can
be made.
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